| （単位：十億ドル） | 1Q12 | 3Q12 | 3Q12 | 1Q13 | 2Q13 | 3Q13 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | 0 | 0 | 0 | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 売上成長率（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| 売上原価 | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 売上総利益 | - | - | - | - | - | - | - | - | - | - | 0 | -1 | -1 | -1 | 0 | 0 | 0 | 0 | -1 |
| 売上総利益率（％） | - | - | - | - | - | - | - | - | - | - | |||||||||
| 研究開発費 | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 販売管理費 | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業費用 | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 営業利益 | - | - | - | - | - | - | - | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| 営業利益率 (%) | - | - | - | - | - | - | - | - | - | - | |||||||||
| 経常（税引前）利益 | -1 | -1 | -1 | -1 | - | - | -1 | - | - | - | 0 | 0 | -1 | -1 | -1 | -1 | -1 | 0 | -1 |
| 経常（税引前）利益率（％） | -Infinity | -Infinity | -Infinity | - | - | - | - | - | - | - | 2774.55 | 33.41 | -964.86 | -992.73 | -509.04 | -294.65 | -350.77 | 1.53 | -1945.52 |
| 法人税等合計 | - | - | - | - | - | - | 0 | - | - | - | - | - | - | - | - | - | - | - | - |
| 実効税率（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 純利益 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | 0 | -1 |
| 純利益率（％） | - | - | - | - | - | - | - | ||||||||||||
| 一株あたり利益 | -0.0 | -0.0 | -0.0 | -0.01 | - | - | - | - | - | - | 0.36 | 0.01 | -0.11 | -0.09 | -0.09 | -0.71 | -0.43 | -0.06 | -0.73 |
| 希薄化後一株あたり利益 | -0.0 | -0.0 | -0.0 | -0.01 | - | - | - | - | - | - | 0.32 | 0.01 | -0.11 | -0.09 | -0.09 | -0.71 | -0.43 | -0.06 | -0.73 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||
| EBITDAマージン（％） | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |